http://www.raredr.com/news/whos-who-nord-conference
Who's Who of the Rare Disease Community to Speak at NORD's Conference

James Radke, PhD

Acting FDA Commissioner Stephen Ostroff among the speakers

The agenda and speakers scheduled for the NORD 2015 Rare Diseases & Orphan Products Breakthrough Summit has been finalized and it is going to be another stellar line up of industry, advocacy, and regulatory leaders speaking at the summit being held in Arlington, Virginia on October 21-22, 2015.

The summit is also the only rare disease conference to be co-sponsored by the FDA. Among the speakers will be FDA dignitaries Stephen Ostroff, MD (Acting Commissioner, FDA) and Janet Woodcock, MD, (Director, Center for Drug Evaluation and Research, FDA). 

Scheduled speakers include:

Scheduled Topics include:

For more information about the conference, visit http://rarediseases.org/summit-overview/
Printer Printing...
$content$